CYTOGENETICAL ANALYSIS OF EFFECT OF 6-MERCAPTOPURINE ON HUMAN CHROMOSOMES .1. EFFECTS ON BLOOD-CELLS OF ACUTE LEUKEMIA PATIENTS

被引：0
|
作者：
FEDORTSE.RF
DYGIN, VP
MAMAEVA, SE
GOROSHCH.YL
机构：
[1] ACAD SCI USSR,CYTOL INST,LAB CELL MORPHOL,LENINGRAD,USSR
[2] MILIT MED ACAD,CHAIR FAC THERAPY,LENINGRAD,USSR
来源：
TSITOLOGIYA | 1973年 / 15卷 / 09期
关键词：
D O I：
暂无
中图分类号：
Q2 [细胞生物学];
学科分类号：
071009 ; 090102 ;
摘要：
引用
收藏
页码：1172 / 1176
页数：5
相关论文
共 50 条
  • [41] A novel 6-mercaptopurine oral liquid formulation for pediatric acute lymphoblastic leukemia patients - results of a randomized clinical trial
    Hanff, Lidwien M.
    Mathot, Ron A. A.
    Smeets, Oscar
    Postma, Doerine J.
    Ramnarain, Satianand
    Vermes, Andras
    Pieters, Rob
    Zwaan, C. Michel
    INTERNATIONAL JOURNAL OF CLINICAL PHARMACOLOGY AND THERAPEUTICS, 2014, 52 (08) : 653 - 662
  • [42] Novel variant in Nudix hydrolase 15 gene influences 6-mercaptopurine toxicity in childhood acute lymphoblastic leukemia patients
    Sabirova, Zarina
    Mahnoor, Shazia
    Lasfar, Dina
    Gagne, Vincent
    Theoret, Yves
    Leclerc, Jean Marie
    Laverdiere, Caroline
    Sinnett, Daniel
    Tran, Thai-Hoa
    Krajinovic, Maja
    PHARMACOGENETICS AND GENOMICS, 2024, 34 (05): : 170 - 173
  • [43] DISRUPTION OF VIRUS BIOSYNTHESIS IN VITRO WITH 6-MERCAPTOPURINE .1. EFFECT ON DNA- + RNA- VIRUSES
    STGEME, JW
    PROCEEDINGS OF THE SOCIETY FOR EXPERIMENTAL BIOLOGY AND MEDICINE, 1964, 116 (01): : 228 - &
  • [44] EFFECTS OF LEVAMISOLE ADMINISTRATION ON TREATMENT WITH 6-MERCAPTOPURINE RIBOSIDE OF MICE BEARING L1210 LEUKEMIA-CELLS
    MIURA, T
    NOGIWA, E
    KURASHIGE, S
    MAEKAWA, T
    CANCER RESEARCH, 1980, 40 (12) : 4813 - 4816
  • [45] MODULATION OF THE EFFECT OF 1-BETA-D-ARABINOFURANOSYLCYTOSINE BY 6-MERCAPTOPURINE IN L1210 CELLS
    KAWAI, Y
    UEDA, T
    NAKAMURA, T
    JAPANESE JOURNAL OF CANCER RESEARCH, 1994, 85 (09): : 978 - 985
  • [46] EFFECT OF 6-MERCAPTOPURINE ON DURATION OF STEROID-INDUCED REMISSIONS IN ACUTE LEUKEMIA - A MODEL FOR EVALUATION OF OTHER POTENTIALLY USEFUL THERAPY
    FREIREICH, EJ
    PINKEL, D
    HAURANI, F
    SCHROEDER, LR
    GENDEL, BR
    ANBARI, R
    FREI, E
    MILLS, SD
    SELAWRY, OS
    STORRS, R
    GEHAN, E
    HOOGSTRATEN, B
    WOLMAN, IJ
    SPURR, CL
    MOON, JH
    BURGERT, EO
    LEE, S
    BLOOD, 1963, 21 (06) : 699 - &
  • [47] ASSAY OF 6-THIOGUANINE NUCLEOTIDE, A MAJOR METABOLITE OF AZATHIOPRINE, 6-MERCAPTOPURINE AND 6-THIOGUANINE, IN HUMAN RED-BLOOD-CELLS
    LENNARD, L
    MADDOCKS, JL
    JOURNAL OF PHARMACY AND PHARMACOLOGY, 1983, 35 (01) : 15 - 18
  • [48] Up-regulation of P-glycoprotein confers acquired resistance to 6-mercaptopurine in human chronic myeloid leukemia cells
    Peng, Xng-Xiang
    Shi, Zhi
    Tiwari, Amit K.
    Damaraju, Vijaya L.
    Fu, Liwu
    Cass, Carol E.
    Ashby, Charles R., Jr.
    Kruh, Gary D.
    Chen, Zhe-Sheng
    ONCOLOGY LETTERS, 2011, 2 (03) : 549 - 556
  • [49] In vitro cytotoxicity analysis on patient-derived PBMCs to predict 6-mercaptopurine therapy response in children with acute lymphoblastic leukemia
    Velugonda, Nagaraj
    Chaitanya, P. Krishna
    Patchva, Dora babu
    Anda, Sasidhar V. M.
    Gundeti, Sad a shivudu
    INDIAN JOURNAL OF BIOCHEMISTRY & BIOPHYSICS, 2024, 61 (06): : 371 - 379
  • [50] RECTAL BIOAVAILABILITY OF 6-MERCAPTOPURINE IN CHILDREN WITH ACUTE LYMPHOBLASTIC-LEUKEMIA - PARTIAL AVOIDANCE OF 1ST-PASS METABOLISM
    KATO, Y
    MATSUSHITA, T
    UCHIDA, H
    EGI, S
    YOKOYAMA, T
    MOHRI, K
    EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY, 1992, 42 (06) : 619 - 622
12345